If you take a GLP-1 medication and you have an upcoming surgery, endoscopy, or any procedure involving sedation, there's a good chance someone on your care team will ask about it before the day arrives. That question isn't a formality. It comes from a real, well-documented effect of how these medications work, and it's become a standard part of pre-operative planning as GLP-1 treatment has grown more common.
This article is patient education, not medical advice. Only an independent licensed medical professional, working with your surgical or anesthesia team, can determine the right plan for your specific procedure.
Why GLP-1 medications come up in surgical planning
Anesthesia and surgical teams build their plans around a simple goal: keeping your airway protected while you're sedated. Part of how they do that is by having you avoid food and liquid for a set window before your procedure, the fasting instructions most people are already familiar with from any past surgery or procedure. Those instructions assume a stomach that empties at a fairly predictable rate.
GLP-1 medications complicate that assumption. Because one of their mechanisms is slowing digestion, a patient who followed standard fasting instructions to the letter could still, in some cases, have more stomach contents remaining than expected. That possibility is why GLP-1 use has become a specific question on many pre-operative checklists, alongside things like current medications, allergies, and prior anesthesia experiences.
This isn't a reason to feel alarmed if you're on a GLP-1 medication and have a procedure coming up. It's a reason to plan ahead with your care team, the same way you would for any other medication that affects how your body responds to sedation.
How GLP-1 medications slow digestion
GLP-1 receptor agonist medications, including semaglutide and tirzepatide, work in part by slowing gastric emptying, the rate at which the stomach empties its contents into the small intestine. This is one of the mechanisms that contributes to reduced appetite and a feeling of fullness after eating, which is part of why these medications are used for chronic weight management and blood sugar control.
That same effect is what draws attention before a procedure. Delayed gastric emptying can mean food eaten well before a standard fasting window still hasn't fully cleared the stomach by the time a procedure begins. This effect isn't unique to any single brand. It applies to FDA-approved products such as Ozempic® and Wegovy® (semaglutide) and Mounjaro® and Zepbound™ (tirzepatide), and it applies just as much to compounded formulations, which are not FDA-approved and have not been reviewed by the FDA for safety, efficacy, or quality, but may be prescribed by an independent licensed physician when clinically appropriate.
For many patients, this effect is most pronounced early in treatment or shortly after a dose increase, and it can also be more noticeable in people who are experiencing GI side effects such as nausea or bloating. That's part of why timing, dosing history, and current symptoms all factor into how a care team thinks about your individual situation, rather than applying one blanket rule to every patient on a GLP-1 medication.
The aspiration risk anesthesia teams consider
Sedation and general anesthesia suppress the reflexes that normally protect your airway, including the cough and swallow reflexes that would otherwise help clear material away from your lungs. If stomach contents are regurgitated while those protective reflexes are blunted, there's a risk that material can be inhaled into the lungs, a complication known as pulmonary aspiration. This is a recognized risk of any anesthesia, which is exactly why standard fasting guidelines exist in the first place.
The American Society of Anesthesiologists has issued guidance encouraging clinicians to consider a patient's GLP-1 medication use when planning sedation or general anesthesia, because of a potential increased risk of retained stomach contents and pulmonary aspiration. That guidance reflects a precautionary approach based on case reports and growing clinical experience, not a claim that every patient on a GLP-1 medication will have a problem. Most procedures for most patients on these medications proceed without incident. The guidance exists so that anesthesia teams have a consistent way to assess and plan for the possibility.
A planning consideration, not a reason to avoid needed care
Being on a GLP-1 medication doesn't mean a procedure is unsafe or should be postponed indefinitely. It means your care team has a specific, well-recognized factor to plan around, the same way they would plan around other medications or health conditions that affect anesthesia. Open communication is what allows that planning to happen.
What current guidance says about timing
Professional guidance in this area has continued to evolve as more clinical experience accumulates, and recommendations can be updated as new evidence emerges. In general terms, guidance in this space has pointed toward considering a period of adjusted dosing or additional precautions around procedures involving sedation, with the specifics depending on factors like the medication's dosing schedule, how recently a dose was taken, and whether a patient has current GI symptoms.
Because guidance continues to be refined and because individual circumstances vary so much, this article intentionally doesn't specify an exact number of days or doses to hold. That kind of specific instruction should come directly from your prescribing clinician in coordination with your anesthesia or surgical team, who can weigh the latest guidance against your particular medication, dose, procedure type, and health history. A generic timeline printed on a website isn't a substitute for that individualized plan.
Some anesthesia teams also use additional precautions on the day of a procedure for patients on GLP-1 medications, such as adjusting the anesthesia technique or confirming an empty stomach with imaging, rather than relying on pause instructions alone. Which approach, or combination of approaches, is used depends on the resources and protocols of the specific facility and care team involved.
What to expect at your pre-operative evaluation
If you take a GLP-1 medication, expect your surgical team or pre-operative nurse to ask specifically about it, including the medication name, dose, and when you last took it. It helps to have this information ready, along with the name and contact information of the clinician who prescribes it, so your surgical team can coordinate directly if needed.
- Bring an accurate, current list of all medications, including the specific GLP-1 medication, its dose, and your usual dosing schedule
- Mention any recent GI symptoms, such as nausea, vomiting, bloating, or feeling unusually full, especially in the days leading up to your procedure
- Ask your prescribing clinician directly whether they recommend any change to your dosing schedule before the procedure, and get that guidance in writing if possible
- Follow any specific dietary instructions your surgical team gives you, which may go beyond standard fasting guidelines for patients on GLP-1 medications
- Confirm the plan with both your prescribing clinician and your surgical team if you receive different instructions from each, rather than choosing one and hoping for the best
If you're early in GLP-1 treatment, our guide to what to expect in your first month of GLP-1 treatment covers how dosing is typically started and adjusted, which is useful background if a procedure falls during that period.
Talking to your prescribing clinician and surgical team together
The most reliable way to handle a GLP-1 medication and an upcoming procedure is to make sure your prescribing clinician and your surgical or anesthesia team are actually talking to each other, or at minimum, that you're relaying complete information between them. Scheduling a procedure is a good moment to mention your GLP-1 treatment to your surgical team as early as possible, ideally as soon as the procedure is scheduled rather than the week before.
Your prescribing clinician can also help you understand how this consideration fits into your broader treatment plan. If a dosing pause is recommended, they can advise on how to resume afterward and what to watch for as you do. This kind of coordinated, individualized planning is part of why GLP-1 treatment, including compounded formulations discussed in our overview of how compounded GLP-1s work, is managed by a licensed clinician rather than handled independently. It's also connected to the broader picture of side effects of GLP-1 medications, since GI symptoms are one of the details your care team will want to know about. You can find more explainers like this one in our Weight Management category, including our overview of what compounded semaglutide is.
If your procedure is urgent or emergency in nature, standard elective-procedure timing considerations may not apply in the same way, and your care team will make decisions based on the immediate clinical situation. In those cases, telling the team about your GLP-1 medication as soon as possible still matters, even if there isn't time for advance planning.
The bottom line
GLP-1 medications slow gastric emptying as part of how they work, and that effect is why anesthesia teams, guided by professional bodies such as the American Society of Anesthesiologists, now routinely ask about GLP-1 use before a procedure involving sedation or general anesthesia. This reflects a recognized, precautionary planning consideration around retained stomach contents and aspiration risk, not a reason to avoid necessary care. Whether and how to adjust your GLP-1 dosing before a procedure is an individualized decision, made by your prescribing clinician together with your surgical or anesthesia team, based on your specific medication, procedure, and health history. Telling your care team about your GLP-1 medication as early as possible is the most useful thing you can do to help that plan come together.
Important Safety Information
Indication. GLP-1 receptor agonists are medications used, when clinically appropriate, to support blood sugar management or chronic weight management alongside a reduced-calorie diet and increased physical activity. FDA-approved brands include Ozempic® and Wegovy® (semaglutide) and Mounjaro® and Zepbound™ (tirzepatide). Compounded GLP-1 medications are not FDA-approved.
Common side effects. The most commonly reported side effects are gastrointestinal, including nausea, diarrhea, vomiting, constipation, abdominal pain, and indigestion. These are often mild and tend to ease over time, especially as the dose is increased gradually.
Warnings. These medications carry a boxed warning regarding thyroid C-cell tumors seen in rodent studies. Do not use if you or a family member has had medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Tell your provider, and your surgical or anesthesia team, about any history of pancreatitis, gallbladder disease, or kidney problems, if you are pregnant, planning to become pregnant, or breastfeeding, and about any upcoming procedures requiring sedation or anesthesia.
Talk to your doctor. This information is educational and is not a substitute for medical advice. Only a licensed medical professional can determine whether a treatment is right for you. Talk to your doctor about the benefits and risks, and report any side effects.
Frequently asked questions
Do I need to stop taking my GLP-1 medication before surgery?
Possibly, but it depends on the procedure, the type of anesthesia planned, and your individual health history. Some patients are asked to pause dosing for a period before a scheduled procedure, while others aren't. This decision is made by your prescribing clinician together with your surgical or anesthesia team, not by a fixed rule that applies to everyone.
Why does a GLP-1 medication matter for anesthesia?
GLP-1 medications work in part by slowing gastric emptying, meaning food and liquid can stay in the stomach longer than usual. During sedation or general anesthesia, the reflexes that normally protect the airway are suppressed, so retained stomach contents raise the risk of regurgitation and pulmonary aspiration. That is why anesthesia teams ask about GLP-1 use during pre-operative planning.
How far in advance should I tell my surgical team about a GLP-1 medication?
As early as possible, ideally when the procedure is first scheduled. This gives your prescribing clinician and your surgical or anesthesia team enough time to coordinate a plan, which may include guidance about dosing, diet in the days before the procedure, or additional precautions on the day itself.
Does this apply to compounded semaglutide and tirzepatide too?
Yes. The gastric-emptying effect comes from the GLP-1 (or combined GLP-1/GIP) mechanism itself, not from a specific brand or formulation. It applies whether you use an FDA-approved product or, when clinically appropriate, a compounded version of semaglutide or tirzepatide, which is not FDA-approved. Tell your surgical team about any GLP-1 medication you take, regardless of source.
What if I have nausea, bloating, or other GI symptoms close to my procedure date?
Tell both your prescribing clinician and your surgical or anesthesia team. Active gastrointestinal symptoms can be a sign that food is moving through your stomach more slowly than usual, which may affect the timing or precautions recommended for your procedure. This is exactly the kind of detail that should shape your individual plan rather than be left unmentioned.
